Possibilities of small-size glioblastoma visualization by PET-CT with 11C-choline (experimental study)-Reference-Cited by-同舟云学术

Possibilities of small-size glioblastoma visualization by PET-CT with 11C-choline (experimental study)

Published:2021-01-12 Issue:4 Volume:11 Page:30-36
ISSN:2079-5343
Container-title:Diagnostic radiology and radiotherapy
language:
Short-container-title:Lučevaâ diagn. ter.

Author:

Kostenikov N. A.¹,Dubrovskaya V. F.¹,Kovan'ko E. G.¹,Mirolyubova O. Yu.¹,Ilyushchenko Yu. R.¹,Stanzhevsky A. A.¹

Affiliation:

1. Granov Russian Research Center of Radiology & Surgical Technology

Abstract

Introduction. The minimum size of malignant brain tumors detected by positron emission and computed tomography (PET-CT) exceeds 6-7 mm. One of the ways to increase the sensitivity of PET-CT in detecting of malignant brain tumors is to increase the administered activity of the radiopharmaceutical 11C-choline.Purpose & tasks. The aim of the study was to experimentally study the possibility of obtaining a small-size glioblastoma (GB) images (up to 4 mm) by PET-CT with the 11C-choline.Materials and methods. The study was performed on 24 rats with implanted intracerebral tumor «Glioma C6» (glioblastoma). Animals underwent magnetic resonance imaging (MRI) with contrast enhancement (CE) and PET-CT with 11C-choline for 21 days after tumor transplantation.Results. It was shown that using two methods: MRI with CE and PET-CT with 11C-choline, a glioblastoma up to 4 mm can be convincingly visualized.Conclusion. The data obtained can be crucial for early detection of glioblastoma, justification of treatment tactics, evaluation of the treatment effectiveness and prediction the outcome of the disease.

Publisher

Baltic Medical Education Center

Subject

General Medicine

Reference13 articles.

1. Olyushin V.E., Filatov M.V., Ulitin A.Yu., Rostovtsev D.M., Faddeva T.N., Maslova L.N., Papayan. G.V. New techniques in therapy of patients with malignant gliomas of hemisphere of the large brain. Practical oncology, 2013, Vol. 14, No. 3, рр. 175-179 (In Russ.).

2. Vajkoczy P., Farhadi M., Gaumann A. et al. Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2 // The Journal of Clinical Investigation. 2002. Vol. 109, No. 6. Р. 777-785.

3. Holzgreve A., Brendel M., Gu S., Carlsen J., Mille E., Boning G., Mastrella G., Unterrainer M., Gildehaus F.J., Rominger A., Bartenstein P. Monitoring of Tumor Growth with [18F]-FET PET in a Mouse Model of Glioblastoma: SUV Measurements and Volumetric Approaches // Frontiers in neuroscience. 2016. Vol. 10. Р. 260. https://doi.org/10.3389/fnins.2016.00260

4. Trikalinos N.A., Nihashi T., Evangelou E., Terasawa T. Positron emission tomography (PET) for prediction of glioma histology: protocol for an individual-level data meta-analysis of test performance // BMJ open. 2018. Vol. 8, No. 2. e020187. http://dx.doi.org/10.1136/bmjopen-2017-020187.

5. Bogsrud T., Londalen A., Brandal P., Leske H., Panagopoulos I., Borghammer P., Bach-Gansmo T. 18F-fluciclovine PET/CT in suspected residual or recurrent high-grade glioma // Clinical nuclear medicine. 2019. Vol. 44, No. 8. Р. 605-611.